|
|
Volumn 34, Issue 5, 2002, Pages 1944-1945
|
|
Effect of daclizumab, tacrolimus, and mycophenolate mofetil in pediatric first renal transplant recipients
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
IMMUNOSUPPRESSIVE AGENT;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
TACROLIMUS;
ALLOANTIBODY;
DACLIZUMAB;
DRUG DERIVATIVE;
IMMUNOGLOBULIN G;
MONOCLONAL ANTIBODY;
MYCOPHENOLIC ACID;
ADOLESCENT;
ADULT;
CHILD;
CLINICAL ARTICLE;
CONFERENCE PAPER;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SAFETY;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY ALLOGRAFT;
KIDNEY ALLOGRAFT REJECTION;
KIDNEY FAILURE;
MALE;
PRIORITY JOURNAL;
VIRUS INFECTION;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
DRUG COMBINATION;
FEMALE;
FOLLOW UP;
HISTOCOMPATIBILITY TEST;
IMMUNOLOGY;
KIDNEY TRANSPLANTATION;
PRESCHOOL CHILD;
RACE;
TIME;
TREATMENT OUTCOME;
UNITED STATES;
ADOLESCENT;
ANTIBODIES, MONOCLONAL;
CHILD;
CHILD, PRESCHOOL;
DRUG THERAPY, COMBINATION;
FEMALE;
FLORIDA;
FOLLOW-UP STUDIES;
HISTOCOMPATIBILITY TESTING;
HUMAN;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENTS;
ISOANTIBODIES;
KIDNEY TRANSPLANTATION;
MALE;
MYCOPHENOLIC ACID;
RACIAL STOCKS;
TACROLIMUS;
TIME FACTORS;
TREATMENT OUTCOME;
CONTINENTAL POPULATION GROUPS;
HUMANS;
|
|
EID: 0035993818
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)03131-7 Document Type: Conference Paper |
|
Times cited : (13)
|
|
References (9)
|
